Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to demonstrate safety and efficacy of liquid risperidone in
psychiatrically hospitalized children, ages 4-12, who would be put in seclusion or restraint,
or given an intramuscular injection of diphenhydramine because of their out-of-control
behavior if not medicated with risperidone. The first part of the study will: 1) develop
appropriate oral doses of medication to reduce out of control or agitated behavior
effectively with the fewest side effects, and 2) develop a rating system to measure the
children's behavior i.e. level of improvement, sedation, and untoward effects.